nodes	percent_of_prediction	percent_of_DWPC	metapath
Rescinnamine—ACE—forelimb—amyotrophic lateral sclerosis	0.0565	0.148	CbGeAlD
Rescinnamine—ACE—hindlimb—amyotrophic lateral sclerosis	0.0509	0.133	CbGeAlD
Rescinnamine—ACE—arm—amyotrophic lateral sclerosis	0.0486	0.127	CbGeAlD
Rescinnamine—ACE—appendage—amyotrophic lateral sclerosis	0.0436	0.114	CbGeAlD
Rescinnamine—ACE—peripheral nervous system—amyotrophic lateral sclerosis	0.0397	0.104	CbGeAlD
Rescinnamine—Osteoporosis—Riluzole—amyotrophic lateral sclerosis	0.0325	0.0647	CcSEcCtD
Rescinnamine—ACE—nerve—amyotrophic lateral sclerosis	0.0309	0.0809	CbGeAlD
Rescinnamine—Psoriasis—Riluzole—amyotrophic lateral sclerosis	0.029	0.0577	CcSEcCtD
Rescinnamine—Tooth disorder—Riluzole—amyotrophic lateral sclerosis	0.0281	0.0559	CcSEcCtD
Rescinnamine—Seborrhoeic dermatitis—Riluzole—amyotrophic lateral sclerosis	0.0267	0.0532	CcSEcCtD
Rescinnamine—SLC18A2—Synaptic Vesicle Pathway—UNC13A—amyotrophic lateral sclerosis	0.0235	0.204	CbGpPWpGaD
Rescinnamine—Abscess—Riluzole—amyotrophic lateral sclerosis	0.023	0.0458	CcSEcCtD
Rescinnamine—Endocrine disorder—Riluzole—amyotrophic lateral sclerosis	0.022	0.0437	CcSEcCtD
Rescinnamine—Accidental injury—Riluzole—amyotrophic lateral sclerosis	0.0206	0.041	CcSEcCtD
Rescinnamine—Cough increased—Riluzole—amyotrophic lateral sclerosis	0.0199	0.0396	CcSEcCtD
Rescinnamine—SLC18A2—brainstem—amyotrophic lateral sclerosis	0.0194	0.0509	CbGeAlD
Rescinnamine—Dermatitis contact—Riluzole—amyotrophic lateral sclerosis	0.018	0.0358	CcSEcCtD
Rescinnamine—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.016	0.0318	CcSEcCtD
Rescinnamine—ACE—embryo—amyotrophic lateral sclerosis	0.0145	0.0379	CbGeAlD
Rescinnamine—Injury—Riluzole—amyotrophic lateral sclerosis	0.0144	0.0286	CcSEcCtD
Rescinnamine—SLC18A2—medulla oblongata—amyotrophic lateral sclerosis	0.0136	0.0355	CbGeAlD
Rescinnamine—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.0117	0.0233	CcSEcCtD
Rescinnamine—Influenza—Riluzole—amyotrophic lateral sclerosis	0.0114	0.0227	CcSEcCtD
Rescinnamine—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.0111	0.0222	CcSEcCtD
Rescinnamine—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.011	0.0219	CcSEcCtD
Rescinnamine—SLC18A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A1—amyotrophic lateral sclerosis	0.011	0.0955	CbGpPWpGaD
Rescinnamine—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.0104	0.0208	CcSEcCtD
Rescinnamine—SLC18A2—nervous system—amyotrophic lateral sclerosis	0.0102	0.0267	CbGeAlD
Rescinnamine—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.01	0.02	CcSEcCtD
Rescinnamine—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00999	0.0199	CcSEcCtD
Rescinnamine—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00991	0.0197	CcSEcCtD
Rescinnamine—SLC18A2—central nervous system—amyotrophic lateral sclerosis	0.00981	0.0257	CbGeAlD
Rescinnamine—SLC18A2—cerebellum—amyotrophic lateral sclerosis	0.00959	0.0251	CbGeAlD
Rescinnamine—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00956	0.019	CcSEcCtD
Rescinnamine—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00917	0.0182	CcSEcCtD
Rescinnamine—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.0091	0.0181	CcSEcCtD
Rescinnamine—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00908	0.0181	CcSEcCtD
Rescinnamine—ACE—spinal cord—amyotrophic lateral sclerosis	0.00826	0.0216	CbGeAlD
Rescinnamine—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.0078	0.0155	CcSEcCtD
Rescinnamine—SLC18A2—brain—amyotrophic lateral sclerosis	0.00779	0.0204	CbGeAlD
Rescinnamine—Back pain—Riluzole—amyotrophic lateral sclerosis	0.0077	0.0153	CcSEcCtD
Rescinnamine—SLC18A2—Amine compound SLC transporters—SLC6A1—amyotrophic lateral sclerosis	0.00762	0.0663	CbGpPWpGaD
Rescinnamine—ACE—nervous system—amyotrophic lateral sclerosis	0.00696	0.0182	CbGeAlD
Rescinnamine—Cough—Riluzole—amyotrophic lateral sclerosis	0.00695	0.0138	CcSEcCtD
Rescinnamine—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00688	0.0137	CcSEcCtD
Rescinnamine—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00678	0.0135	CcSEcCtD
Rescinnamine—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.0067	0.0133	CcSEcCtD
Rescinnamine—ACE—central nervous system—amyotrophic lateral sclerosis	0.0067	0.0175	CbGeAlD
Rescinnamine—SLC18A2—Neurotransmitter Release Cycle—CHAT—amyotrophic lateral sclerosis	0.00654	0.0568	CbGpPWpGaD
Rescinnamine—Oedema—Riluzole—amyotrophic lateral sclerosis	0.0065	0.0129	CcSEcCtD
Rescinnamine—Infection—Riluzole—amyotrophic lateral sclerosis	0.00646	0.0128	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00592	0.0118	CcSEcCtD
Rescinnamine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00588	0.0117	CcSEcCtD
Rescinnamine—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00584	0.0116	CcSEcCtD
Rescinnamine—SLC18A2—Neurotransmitter Release Cycle—SLC6A1—amyotrophic lateral sclerosis	0.00582	0.0506	CbGpPWpGaD
Rescinnamine—SLC18A2—Synaptic Vesicle Pathway—SLC1A3—amyotrophic lateral sclerosis	0.0056	0.0486	CbGpPWpGaD
Rescinnamine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00556	0.0111	CcSEcCtD
Rescinnamine—Pain—Riluzole—amyotrophic lateral sclerosis	0.00556	0.0111	CcSEcCtD
Rescinnamine—ACE—brain—amyotrophic lateral sclerosis	0.00532	0.0139	CbGeAlD
Rescinnamine—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00532	0.0106	CcSEcCtD
Rescinnamine—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00516	0.0103	CcSEcCtD
Rescinnamine—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00514	0.0102	CcSEcCtD
Rescinnamine—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00479	0.00953	CcSEcCtD
Rescinnamine—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.0046	0.00915	CcSEcCtD
Rescinnamine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.0043	0.00855	CcSEcCtD
Rescinnamine—Rash—Riluzole—amyotrophic lateral sclerosis	0.0041	0.00815	CcSEcCtD
Rescinnamine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.0041	0.00815	CcSEcCtD
Rescinnamine—Headache—Riluzole—amyotrophic lateral sclerosis	0.00407	0.0081	CcSEcCtD
Rescinnamine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00386	0.00768	CcSEcCtD
Rescinnamine—ACE—Metabolism of proteins—IGFALS—amyotrophic lateral sclerosis	0.00338	0.0293	CbGpPWpGaD
Rescinnamine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.00298	0.0259	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—PIGW—amyotrophic lateral sclerosis	0.00256	0.0222	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00247	0.0215	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—XRN2—amyotrophic lateral sclerosis	0.00234	0.0203	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00228	0.0199	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00221	0.0192	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00202	0.0175	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—YIF1A—amyotrophic lateral sclerosis	0.00194	0.0169	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.0019	0.0165	CbGpPWpGaD
Rescinnamine—ACE—Peptide hormone metabolism—IGF1—amyotrophic lateral sclerosis	0.00189	0.0164	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00188	0.0163	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00188	0.0163	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00179	0.0155	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00175	0.0152	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00169	0.0147	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00167	0.0145	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	0.0016	0.0139	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00155	0.0134	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00152	0.0132	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00144	0.0125	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00144	0.0125	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00141	0.0123	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00135	0.0118	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	0.00134	0.0117	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00128	0.0111	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	0.00114	0.00993	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000909	0.0079	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	0.000844	0.00734	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000772	0.00672	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000772	0.00672	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000689	0.00599	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	0.000357	0.0031	CbGpPWpGaD
